Network Profile
A curated network of independently operated, rigorously vetted clinical research sites — delivering enrollment velocity, data quality, and patient diversity across 15 therapeutic areas and 8 U.S. states.
Network Overview
Every site in the Clinitiative network is independently owned and operated — selected through a rigorous multi-stage vetting process and continuously monitored under our ClinFirst™ governance framework. This model preserves the entrepreneurial agility of independent sites while enforcing the consistency, compliance, and performance accountability that sponsors require.
Our philosophy is simple: curate fewer, better sites — then invest deeply in their success. Rather than chasing scale for its own sake, we build lasting partnerships with high-performing investigators who share our commitment to enrollment excellence and patient-centered research.
Therapeutic Breadth Across the Network
Our sites maintain active capabilities across 15 therapeutic areas — enabling multi-indication feasibility and rapid protocol matching for sponsors with diversified pipelines.
Built on Independence
The independent-site model is not a limitation — it is our competitive advantage. Every site in the network retains operational autonomy while aligning to centralized governance and performance standards.
Independently Owned & Operated
Each site is led by a physician-owner with deep roots in their community. This autonomy enables faster decision-making, entrepreneurial drive, and genuine accountability that centralized site networks cannot replicate.
Rigorous Vetting & Qualification
Every site undergoes a multi-stage evaluation including operational assessment, regulatory history review, and baseline SiteScore™ methodology before receiving network admission.
Proven Track Record
Sites are selected based on demonstrated enrollment velocity, data quality metrics, and documented sponsor feedback — not aspirational capability statements.
Continuous Performance Monitoring
Ongoing SiteScore™ evaluation, quality metrics tracking, and governance compliance audits ensure sustained excellence throughout the life of every study.
How Sites Enter Our Network
Admission to the Clinitiative network is selective and structured. Every prospective site passes through a four-stage qualification process before receiving governance integration.
Prospective sites submit a comprehensive application covering operational history, therapeutic experience, investigator credentials, regulatory compliance history, and patient population demographics. Our team conducts an initial desk review to assess baseline alignment with network standards.
Qualified applicants receive an on-site evaluation covering physical infrastructure, staffing capacity, pharmacy capabilities, laboratory partnerships, IRB relationships, and existing technology systems. Assessors evaluate operational readiness against a standardized 85-point checklist.
Every site undergoes a comprehensive SiteScore™ baseline assessment — quantifying enrollment capacity, data quality history, regulatory compliance track record, patient diversity access, and operational efficiency metrics. Sites must meet minimum threshold scores across all five domains.
Accepted sites are onboarded into the ClinFirst™ governance framework — establishing standard operating procedures, communication protocols, reporting cadences, audit readiness standards, and continuous performance monitoring through real-time SiteScore™ dashboards.
Commitment to Diverse Enrollment
Clinical research must reflect the communities it serves. Our network is intentionally built to reach underrepresented populations — through strategic site placement, culturally competent engagement, and enrollment practices designed to reduce access barriers.
vs. 20% industry average
Diversity is not a checkbox — it is an operational commitment embedded in site selection, community engagement, and enrollment strategy. Our sites maintain multilingual coordinator staffing, transportation assistance programs, and established relationships with community health organizations that serve as trusted patient referral pathways.
Regional Capabilities
Each state in our network brings distinct therapeutic strengths, patient population characteristics, and investigator expertise — enabling precise site-to-protocol matching.
Houston, Dallas, San Antonio
Oncology, Cardiovascular, Metabolic
Denver
Gastroenterology, Pulmonology, Rare Disease
Los Angeles, San Diego
Dermatology, Immunology, Ophthalmology
Miami, Tampa, Orlando
CNS, Neurology, Cardiovascular
Oklahoma City, Tulsa
Endocrinology, Metabolic, Obesity
Las Vegas
Infectious Disease, Pulmonology
Atlanta
Hematology, Oncology, Infectious Disease
Charlotte, Raleigh
Rheumatology, Nephrology, Rare Disease
Recognized Across the Industry
Our network's reputation is built on measurable results — not marketing claims. These benchmarks reflect real sponsor outcomes and regulatory performance across our site portfolio.
Our investigators are active contributors at ACRP, DIA, SCRS, and MAGI conferences — presenting on enrollment optimization, diversity strategies, and site management best practices. Network leadership maintains ongoing advisory relationships with FDA and industry working groups focused on decentralized trial design and site modernization.
Partner with Our Network
Connect with our team to explore site capabilities, enrollment strategies, and therapeutic coverage for your clinical development program.